Asunaprevir
CAS No. 630420-16-5
Asunaprevir( BMS-650032 | BMS650032 | Asunaprevir )
Catalog No. M18929 CAS No. 630420-16-5
Asunaprevir is an effective hepatitis C virus (HCV) NS3 protease inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 174 | In Stock |
|
| 5MG | 107 | In Stock |
|
| 10MG | 180 | In Stock |
|
| 25MG | 354 | In Stock |
|
| 50MG | 529 | In Stock |
|
| 100MG | 762 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1572 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAsunaprevir
-
NoteResearch use only, not for human use.
-
Brief DescriptionAsunaprevir is an effective hepatitis C virus (HCV) NS3 protease inhibitor.
-
DescriptionAsunaprevir, also known as BMS-650032, is an inhibitor of the hepatitis C virus enzyme serine protease NS3. Asunaprevir is being tested in combination with pegylated interferon and ribavirin, as well as in interferon-free regimens with other direct-acting antiviral agents including daclatasvir.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS-650032 | BMS650032 | Asunaprevir
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorHCV NS3/4A protease
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number630420-16-5
-
Formula Weight748.29
-
Molecular FormulaC35H46ClN5O9S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 42.9 mg/mL; 57.33 mM
-
SMILESO=C([C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)N5C[C@H](Oc1ncc(OC)c2ccc(Cl)cc12)C[C@H]5C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4
-
Chemical Name1,1-dimethylethyl ((1S)-1-{((2S,4R)-4-(7-chloro-4-methoxyisoquinolin-1-yloxy)-2-({(1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-ethenylcyclopropyl}carbamoyl) pyrrolidin-1-yl)carbonyl}-2,2-dimethylpropyl)carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pelosi LA, et al. Effect on HCV Replication by Combinations of Direct Acting Antivirals Including NS5A Inhibitor Daclatasvir. Antimicrob Agents Chemother. 2012 Jul 30.
molnova catalog
related products
-
BTA-9881
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
-
BP-5-087
A potent, selective STAT3 SH2 domain inhibitor (EC50=5.6 uM) that reduces STAT3 phosphorylation and nuclear transactivation.
-
Suptavumab
Suptavumab (REGN2222) is a human monoclonal antibody that neutralizes conserved epitopes on subtypes A and B of RSV, making it useful for studying RSV infections and the respiratory system.
Cart
sales@molnova.com